MedTrace Logo

Vitamin D Testing and Treatment for COVID 19

NCT04407286 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2021-12-30

No results posted yet for this study

Summary

This study will measure vitamin D levels in adults with COVID 19. Participants with low levels of vitamin D will be entered into an open label trial of supplementation with vitamin D.

Conditions

  • Covid 19
  • Vitamin D Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Oral vitamin D3 capsules

Sponsors & Collaborators

  • Southwest College of Naturopathic Medicine

    collaborator OTHER

  • Arizona State University

    lead OTHER

Principal Investigators

  • James B Adams, PhD · Arizona State University

  • Sarah Trahan, NMD · Southwest College of Naturopathic Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-19
Primary Completion
2020-08-30
Completion
2020-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04407286 on ClinicalTrials.gov